價(jià)格 | ¥245 | ¥349 | ¥567 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 AK-7 | 英文名稱:AK-7 |
CAS:420831-40-9 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 98.43% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T5490 |
名稱 | AK-7 |
描述 | AK-7 is a brain-permeable SIRT2 inhibitor and to characterize its cholesterol-reducing properties in neuronal models with an IC50 of 15.5 μM. |
細(xì)胞實(shí)驗(yàn) | Neuronal nuclear antigen (NeuN)-positive neurons and some astroglia were derived from mechanically dissociated ganglionic eminences of E16 rat embryos. The HD model based on the expression of mutant huntingtin has been described previously. Treatments of cultures with AK-7 were at 10 μM for 24 h unless stated otherwise. DMSO was included at the same concentrations as a control. Lower dose, chronic treatments with AK-7 were introduced to neurons at DIV4 and continued weekly coinciding with normal medium change [1]. |
激酶實(shí)驗(yàn) | Sirtuin activity was assessed using the Fleur de Lys assay with recombinant active enzymes SIRT1, SIRT2, and the catalytically active fragment of SIRT3. Results were measured using a Multilabel plate reader (excitation 355 nm, emission 460 nm). Assays were performed using the manufacturer's recommendations, and each compound concentration was tested in triplicate. For each experiment, SIRT1 activity was normalized to 1 U/reaction well and SIRT2 and SIRT3 activity to 5 U/reaction well (where U = 1 pmol/min at 37 °C, 250 μM substrate, 500 μM NAD+). Each reaction well-contained enzyme, 500 μM NAD+, 250 μM fluorogenic deacetylase substrate, supplied reaction buffer, and the compound of interest or mock control (DMSO) in a total volume of 50 μL. Autofluorescent backgrounds were measured in triplicate in reaction solutions containing substrate, buffer, and NAD+ in triplicate and subtracted from experimental signals [1]. |
動(dòng)物實(shí)驗(yàn) | AK-7, solubilized at 1.5 mg/mL in 25% Cremophor EL (BASF)/ 10% DMSO in water, was administered by intraperitoneal injection to 11 week old mice at 15 mg/kg/dose. Blood was collected and centrifuged at 7,000 rpm for 7 min, and then serum was aspirated and immediately frozen in liquid nitrogen. Brains were immediately frozen in liquid nitrogen and stored at -80 C. Brains were weighed and then homogenized in four volumes of 10% Cremophor RH40 in water using homogenizer, and 2% v/v phosphoric acid was added to the homogenate, vortexed, and centrifuged at 10,000g at 25 C for 1 h. The supernatant was aspirated, and solid phase extraction was performed immediately. Serum samples were vortexed into 2% v/v phosphoric acid and centrifuged at 2500 rpm for 10 min[1] |
體外活性 | AK-7 is a selective cell- and brain-permeable SIRT2 inhibitor,this SIRT2 inhibitor stimulated cytoplasmic retention of sterol regulatory element binding protein-2 and subsequent transcriptional downregulation of cholesterol biosynthesis genes, resulting in reduced total cholesterol in primary striatal neurons. Furthermore, the identified inhibitor reduced cholesterol in cultured na?ve neuronal cells and brain slices from wild-type mice[1].AK-7 has roles in metabolic diseases, cancer, age-related disorders, and neurodegenerative diseases, potentially including Alzheimer's, Huntington's, and Parkinson's diseases[2][3]. |
體內(nèi)活性 | AK-7 (15 mg/kg/dose, i.p.) is brain-permeable in wild-type and HD mice[1]. |
存儲(chǔ)條件 | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (114.32 mM) |
關(guān)鍵字 | AK-7 | Sirtuin | AK7 | AK 7 | Inhibitor | inhibit |
相關(guān)產(chǎn)品 | Fisetin | Nicotinamide riboside | Nicotinamide | Resveratrol | Dihydrocoumarin | Sirtinol | JGB1741 | SRT 2104 | Nicotinamide riboside chloride | 3-TYP | SIRT6-IN-5 | MC3482 |
相關(guān)庫 | 抑制劑庫 | 血腦屏障通透化合物庫 | 抗癌化合物庫 | 組蛋白修飾化合物庫 | 抗糖尿病庫 | 抗衰老化合物庫 | HIF-1化合物庫 | 谷氨酰胺代謝化合物庫 | 表觀遺傳庫 | 細(xì)胞重編程化合物庫 |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP4年
|
河源廣譜生物技術(shù)有限公司
|
2024-12-08 | |
詢價(jià) |
VIP5年
|
武漢華玖醫(yī)藥科技有限公司
|
2025-01-10 | |
¥45 |
VIP6年
|
南京松冠生物科技有限公司
|
2025-01-11 | |
詢價(jià) |
VIP8年
|
山東辰熙醫(yī)藥科技有限公司
|
2025-01-11 | |
¥1050.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |